Yalcin-Mutlu, M.; Icacan, O.C.; Yildirim, F.; Temiz, S.A.; Fagni, F.; Schett, G.; Tascilar, K.; Minopoulou, I.; Burul, G.; Bes, C.
IL-1 Inhibitors in the Treatment of Familial Mediterranean Fever: Treatment Indications and Clinical Features in a Large Real-World Cohort. J. Clin. Med. 2024, 13, 3375.
https://doi.org/10.3390/jcm13123375
AMA Style
Yalcin-Mutlu M, Icacan OC, Yildirim F, Temiz SA, Fagni F, Schett G, Tascilar K, Minopoulou I, Burul G, Bes C.
IL-1 Inhibitors in the Treatment of Familial Mediterranean Fever: Treatment Indications and Clinical Features in a Large Real-World Cohort. Journal of Clinical Medicine. 2024; 13(12):3375.
https://doi.org/10.3390/jcm13123375
Chicago/Turabian Style
Yalcin-Mutlu, Melek, Ozan Cemal Icacan, Fatih Yildirim, Selahattin Alp Temiz, Filippo Fagni, Georg Schett, Koray Tascilar, Ioanna Minopoulou, Gokhan Burul, and Cemal Bes.
2024. "IL-1 Inhibitors in the Treatment of Familial Mediterranean Fever: Treatment Indications and Clinical Features in a Large Real-World Cohort" Journal of Clinical Medicine 13, no. 12: 3375.
https://doi.org/10.3390/jcm13123375
APA Style
Yalcin-Mutlu, M., Icacan, O. C., Yildirim, F., Temiz, S. A., Fagni, F., Schett, G., Tascilar, K., Minopoulou, I., Burul, G., & Bes, C.
(2024). IL-1 Inhibitors in the Treatment of Familial Mediterranean Fever: Treatment Indications and Clinical Features in a Large Real-World Cohort. Journal of Clinical Medicine, 13(12), 3375.
https://doi.org/10.3390/jcm13123375
